KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Intangibles (2018 - 2025)

Takeda Pharmaceutical (TAK) has 3 years of Intangibles data on record, last reported at $23.8 billion in Q1 2025.

  • For Q1 2025, Intangibles changed N/A year-over-year to $23.8 billion; the TTM value through Mar 2025 reached $23.8 billion, changed N/A, while the annual FY2025 figure was $23.8 billion, N/A changed from the prior year.
  • Intangibles reached $23.8 billion in Q1 2025 per TAK's latest filing, down from $36.9 billion in the prior quarter.
  • Across five years, Intangibles topped out at $36.9 billion in Q1 2021 and bottomed at $23.8 billion in Q1 2025.